Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group (Q50561845)
Jump to navigation
Jump to search
scientific article published in May 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group |
scientific article published in May 1998 |
Statements
Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group (English)
1 reference
Keldsen N
1 reference
Madsen EL
1 reference
Havsteen H
1 reference
Kamby C
1 reference
Laursen L
1 reference
Sandberg E
1 reference
1 May 1998
1 reference
69
1 reference
2
1 reference
100-102
1 reference